The Neuroscience Chronicles

Short Communication Open Access

MicroRNA silencing: A promising therapy for Alzheimer’s disease

Neelima B. Chauhan

Alzheimer’s disease (AD) is a global health crisis currently afflicting ~6 million Americans (and ~40 million people worldwide). By the middle of the century, these numbers will stagger by ~16 million Americans (and ~152 million people worldwide) suffering from AD, if breakthrough disease-modifying treatments are not discovered.

Neurosci Chron, 2020, Volume 1, Issue 1, p11-15 | DOI: 10.46439/Neuroscience.1.004

Commentary Open Access

ALS Skeletal Muscle: Victim or Culprit

Agnes Badu-Mensah M.Sc, Xiufang Guo Ph. D., James J. Hickman Ph. D.

Aside its function in locomotion, posture maintenance and respiration, the hSKM is reported to be a critical metabolic regulator [1]. The hSKM is acknowledged as the primary site of glucose metabolism and storage [1]. Additionally, it serves as a reserve for amino acids [1,2]. In recently times, the hSKM has also been described as an endocrine organ.

Neurosci Chron, 2021, Volume 2, Issue 2, p31-33 | DOI: 10.46439/Neuroscience.2.012